Middletown, DE -- (SBWIRE) -- 09/11/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: FuelCell Energy Inc (NASDAQ:FCEL), RR Donnelley & Sons Co(NASDAQ:RRD), Astex Pharmaceuticals, Inc.(NASDAQ:ASTX), Avanir Pharmaceuticals Inc(NASDAQ:AVNR)
FuelCell Energy Inc(NASDAQ:FCEL) gained volume of 3.33 million shares and the average volume of the stock remained 1.70 million shares. The 52 week range of the stock remained $0.83 - $1.64 and the day range was $1.29 - $1.39.The stock opened the session at $1.38, and closed the session at $1.29. The stock showed a negative performance of -5.15% in previous trading session. FuelCell Energy, Inc., together with its subsidiaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed baseload power generation. It offers Direct FuelCell power plants that electrochemically produce electricity and heat using various fuels.
Has FCEL Found The Bottom and Ready To Move Up? Find Out Here
In previous session, RR Donnelley & Sons Co (NASDAQ:RRD) traded 3.32 million shares and the average volume of the stock remained 3.05 million shares. The 52 week range of the stock remained $8.30 - $19.42. The stock was a bull and advanced +2.60%, while its closing price stayed at $16.75. The market capitalization of the stock remained 3.04 billion. The half-yearly trend of the stock remained positive +56.5%. R.R. Donnelley & Sons Company provides integrated communication solutions to private and public sectors worldwide. The company offers label and paperboard packaging products, as well as prime label, corrugated, and other packaging products; custom packaging comprising design, printing, die cutting, finishing, and assembling.
For How Long RRD will fight for Profitability? Read This Trend Analysis report
Astex Pharmaceuticals, Inc.(NASDAQ:ASTX) volume of the stock was 3.27 million shares in the most recent session and the average volume remained 4.19 million shares. The stock plunged -2.48% and finished the prior session at the closing price of $8.64. The stock traded 3.27 million shares in its previous trading session and its average volume remained 4.19 million shares. Astex Pharmaceuticals, Inc. engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology using its fragment-based drug discovery platform, Pyramid. The company offers Dacogen (decitabine) for injection for the treatment of patients with myelodysplastic syndrome (MDS).
Why Should Investors Buy ASTX After the Recent Fall? Just Go Here and Find Out
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) traded with volume of 3.19 million shares and the average volume of the stock remained 2.65 million shares. The stock decreased -5.47% and finished the trading at $5.53. The market capitalization of the stock remained 804.44 million. The beta of the stock remained 1.82. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. It primarily offers NUEDEXTA.
Will AVNR Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/